MX2024012228A - Formas cristalinas de un antibiotico peptidico macrociclico - Google Patents
Formas cristalinas de un antibiotico peptidico macrociclicoInfo
- Publication number
- MX2024012228A MX2024012228A MX2024012228A MX2024012228A MX2024012228A MX 2024012228 A MX2024012228 A MX 2024012228A MX 2024012228 A MX2024012228 A MX 2024012228A MX 2024012228 A MX2024012228 A MX 2024012228A MX 2024012228 A MX2024012228 A MX 2024012228A
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline forms
- macrocyclic peptide
- peptide antibiotic
- methods
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22167057 | 2022-04-07 | ||
| PCT/EP2023/058906 WO2023194418A1 (en) | 2022-04-07 | 2023-04-05 | Crystalline forms of a macrocyclic peptide antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024012228A true MX2024012228A (es) | 2024-11-08 |
Family
ID=81448543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024012228A MX2024012228A (es) | 2022-04-07 | 2024-10-03 | Formas cristalinas de un antibiotico peptidico macrociclico |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4504749A1 (enExample) |
| JP (1) | JP2025511869A (enExample) |
| KR (1) | KR20240169690A (enExample) |
| CN (1) | CN118974073A (enExample) |
| AU (1) | AU2023250008A1 (enExample) |
| CA (1) | CA3255726A1 (enExample) |
| IL (1) | IL315686A (enExample) |
| MX (1) | MX2024012228A (enExample) |
| TW (1) | TW202404991A (enExample) |
| WO (1) | WO2023194418A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026154152A1 (en) * | 2025-01-20 | 2026-07-23 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions comprising an antibiotic macrocyclic peptide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
-
2023
- 2023-04-05 WO PCT/EP2023/058906 patent/WO2023194418A1/en not_active Ceased
- 2023-04-05 JP JP2024559427A patent/JP2025511869A/ja active Pending
- 2023-04-05 KR KR1020247036516A patent/KR20240169690A/ko active Pending
- 2023-04-05 CN CN202380032881.2A patent/CN118974073A/zh active Pending
- 2023-04-05 CA CA3255726A patent/CA3255726A1/en active Pending
- 2023-04-05 AU AU2023250008A patent/AU2023250008A1/en active Pending
- 2023-04-05 EP EP23718634.1A patent/EP4504749A1/en active Pending
- 2023-04-05 IL IL315686A patent/IL315686A/en unknown
- 2023-04-06 TW TW112112829A patent/TW202404991A/zh unknown
-
2024
- 2024-10-03 MX MX2024012228A patent/MX2024012228A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN118974073A (zh) | 2024-11-15 |
| CA3255726A1 (en) | 2023-10-12 |
| EP4504749A1 (en) | 2025-02-12 |
| IL315686A (en) | 2024-11-01 |
| WO2023194418A1 (en) | 2023-10-12 |
| TW202404991A (zh) | 2024-02-01 |
| KR20240169690A (ko) | 2024-12-03 |
| AU2023250008A1 (en) | 2024-10-03 |
| JP2025511869A (ja) | 2025-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20210855A1 (es) | Peptidos macrociclicos contra actinetobacter baumannii | |
| DE69332377T2 (de) | Verfahren zur modifizierung rekombinanter polypeptide | |
| JP2002505292A5 (enExample) | ||
| NO2005020I1 (no) | Caspofungin, eventuelt i form av et farmasøytisk akseptabelt salt særlig caspofunginacetat | |
| ES2170239T3 (es) | Peptidos antifungicos de d-aminoacidos basados en histatina. | |
| ES2188644T3 (es) | Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas. | |
| TR200402579T4 (tr) | Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı | |
| NO2013017I1 (no) | (a)dekstrometorfan eller et farmasøytisk akseptabelt salt, en forløper eller derivat, for eksempel ekstrometorfanhydrobromid og spesielt dekstrometorfanhydrobromid monohydrat; og (b) quinidin eller etfarmasøytisk akseptabelt salt, en forløper eller derivat derav, for eksempel quinidin og spesielt quinidinsulfat dihydrat | |
| CY1107724T1 (el) | Νεα πεπτιδια | |
| DK1301196T3 (da) | Stimulering af knoglevækst med peptidderivater af thrombin | |
| BR0305628A (pt) | Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso | |
| CY1114853T1 (el) | Μεθοδοι χορηγησης ν-(5-tert-βουτυλ-ισοξαζολυλ-3-υλο)-ν'-{4-[7-(2-μορφολιν-4-υλο-αιθοξυ)ιμιδαζο[2,1-β][1,3]βενζοθειαζολ-2-υλο]φαινυλ]ουριας για αντιμετωπιση υπερπλαστικων νοσων | |
| ATE358474T1 (de) | Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung | |
| CR7195A (es) | Nuevos derivados de oxazolidinonas como antibacterianos | |
| ATE556088T1 (de) | Konjugat beinhaltend cephalosporin und glykopeptidantibiotikum | |
| CY1112173T1 (el) | Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας | |
| EP4678173A3 (en) | Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use | |
| ES2197840T1 (es) | Metodo para producir y usar nuevas defensinas humanas como proteinas biologicamente activas para tratar infecciones y otras enfermedades. | |
| RU2004103097A (ru) | Способ хирургического лечения осложненных язв задней стенки желудка | |
| DE60313444D1 (de) | Vegf-peptide und deren verwendung | |
| WO2002062944A2 (en) | Novel physiologically active peptide and use thereof | |
| AP2003002897A0 (en) | Processes and intermediates for preparing benzyl epoxides | |
| RU2003108464A (ru) | Способ фармакологической коррекции эндогенной интоксикации при остром деструктивном панкреатите | |
| RU2212854C1 (ru) | Способ эндовидеохирургического лечения паховых грыж у детей | |
| RU96112861A (ru) | Способ дренирования заднего средостения передним наддиафрагмальным внеплевральным доступом |